William Blair
http://www.williamblair.comWilliam Blair & Company, L.L.C. is a Chicago-based investment firm offering investment banking, asset management, equity research, institutional and private brokerage, and private capital to individual, institutional, and issuing clients. Since 1935, it has been committed to helping clients achieve their financial objectives.
View Older Stories View More Recent Stories
-
Agenus to Participate in Resistance-Focused Oncology Panel at the William Blair Biotech Focus Conference 2021
-
Kinnate Biopharma Inc. to Participate in the William Blair Biotech Focus Conference 2021
-
Agenus to Participate in Resistance-Focused Oncology Panel at the William Blair Biotech Focus Conference 2021
-
Eyenovia to Participate in Two Upcoming Investor Conferences
-
Celyad Oncology to Participate at the William Blair Biotech Focus Conference 2021
-
Ramaco Resources, Inc. Announces Public Offering of Senior Unsecured Notes Due 2026
-
Celyad Oncology to Participate at the William Blair Biotech Focus Conference 2021
-
Stevanato Group Launches Roadshow for Proposed Initial Public Offering
-
Codiak BioSciences to Present at the Virtual William Blair Biotech Focus Conference 2021
-
Replimune to Present at the William Blair Biotech Focus Conference 2021
-
Jounce Therapeutics to Participate in William Blair’s Biotech Focus Conference
-
Aravive to Participate in Fireside Chat at 2021 William Blair Biotech Focus Conference
-
Icosavax Inc. (ICVX) Files up to $100M IPO
-
Vestar Capital Partners Acquires Stratus, a Global Leader in Brand Implementation and Facilities Services, from Arcapita
-
Crescendo to Participate in Upcoming Investor Events
-
Teads (TEAD) Files $100M IPO
-
Traeger (COOK) Files $100M IPO
-
Traeger Announces Filing of Registration Statement for Proposed Initial Public Offering
-
Teads Files Registration Statement for Proposed Initial Public Offering
-
Praxis Precision Medicines to Present at Upcoming Investor Conferences
-
Cardiff Oncology to Participate in a Fireside Chat at the William Blair Biotech Focus Conference 2021
-
Brickell Biotech to Participate at William Blair’s Biotech Focus Conference 2021
-
Membership Collective Group, INC. Announces Launch of Initial Public Offering
-
William Blair Starts Zeta Global Holdings Corp (ZETA) at Outperform Citing Unique Data Asset
-
William Blair Starts TaskUs, Inc (TASK) at Outperform
-
UPDATE: William Blair Starts monday.com Ltd. (MNDY) at Outperform
-
UPDATE: William Blair Starts 1stdibs.com (DIBS) at Outperform
-
UPDATE: William Blair Starts Lifestance Health Group (LFST) at Outperform
-
UPDATE: William Blair Starts Marqeta Inc. (MQ) at Outperform
-
Treo Ventures Announces the Successful IPO of its Portfolio Company CVRx® (NSDQ: CVRX)
-
Blend Labs (BLND) Announces 20M Share IPO at $16-$18/sh
-
Blend Announces Launch of Initial Public Offering
-
Xometry Announces Closing of Initial Public Offering
-
CVRx, Inc. Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
-
CVRx, Inc. Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
-
GigInternational1, Inc. Announces the Separate Trading of its Common Stock and Warrants Commencing July 9, 2021
-
AvePoint Closes Business Combination; to Begin Trading on Nasdaq as "AVPT"
-
Riskified Announces Filing of Registration Statement for Proposed Initial Public Offering
-
Torrid Holdings (CURV) IPO 11% Higher
-
Sachem Capital Corp. Announces Partial Exercise of Overallotment Option From Public Offering of Preferred Stock
-
Palomar Holdings (PLMR) is Coming Out of the Penalty Box - William Blair
-
Grid Dynamics Holdings, Inc. (GDYN) Prices 10.1M Share Follow-on Offering at $15.03/sh
-
Grid Dynamics Announces Pricing of Follow-On Offering
-
ASGN Inc. (ASGN) Agrees to Sell Oxford Global Resources for $525M; Revises Guidance Upwards
-
ASGN Announces Agreement to Sell Oxford Global Resources
-
Vera Whole Health and Clayton, Dubilier & Rice Form Investment Partnership to Advance Vera's Value-Based Healthcare Model
-
Torrid Holdings Inc. (CURV) Prices 11M Share IPO at $21/sh
-
BTRS Holdings (BTRS) Prices 9M Share Secondary Offering at $12.25/sh
-
Hansa Biopharma to host conference call to provide interim results for first half 2021 and Business Update
-
Torrid Holdings Inc. Announces Pricing of Initial Public Offering

